20 May 2013
Keywords: pioglitazone, competition, rezulin/avandia, takeda, japan, glitazone, drug
Article | 26 November 1998
Takeda of Japan's glitazone drug for diabetes mellitus, pioglitazone,looks set to offer strong competition to both Sankyo/Warner-Lambert's Rezulin ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.